Navigation Links
Gene linked to schizophrenia may reduce cancer risk
Date:1/19/2010

People who inherit a specific form of a gene that puts them on a road to schizophrenia may be protected against some forms of cancer, according to a new study by scientists at The Feinstein Institute for Medical Research.

The MET proto-oncogene is activated in a variety of tumor malignancies. The gene has recently also been linked to autism and has a role in neurodevelopment, which is why Katherine E. Burdick, PhD and her colleagues decided to look for a relationship between MET and schizophrenia in their large sample of patients. Such an association may help explain the family-based data that suggest that inheriting an enhanced risk for schizophrenia reduces one's chances of developing cancer.

In a study published in the American Journal of Psychiatry, Dr. Burdick and colleagues examined the relationship between 21 single-nucleotide polymorphisms (SNPs) in MET and schizophrenia in 173 patients and 137 normal volunteers. They found that several varieties of MET influenced the risk for schizophrenia, as well as general cognitive ability. The authors were able to replicate their findings in a second sample of 107 patients and 112 healthy volunteers. "The results add to the growing evidence suggesting an intriguing relationship between cancer-related genes and schizophrenia susceptibility," the scientists wrote.

It remains unclear exactly how the gene actually may increase the risk for schizophrenia while protecting against some forms of cancer. However, evidence from research on MET in autism provides some insight. Specifically, it is known that MET is activated (increased activity) when tumors develop and can increase the chance that cancer cells multiply and infiltrate other tissue.

The activation of MET during normal neurodevelopment is critical to ensure that neurons grow and migrate to position themselves correctly in the human cortex. In autism, it appears that while the brain is developing, reduced MET activi
'/>"/>

Contact: Jamie Talan
jtalan@nshs.edu
516-562-1232
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Page: 1 2

Related biology news :

1. Higher opioid dose linked to overdose risk in chronic pain patients
2. Stable climate and plant domestication linked
3. Coal from mass extinction era linked to lung cancer mystery
4. Study provides insight into pathway linked to obesity
5. A global breakthrough in the study of a protein linked to the spread of viruses
6. Pollution linked to hospitalizations for pneumonia in older adults
7. Gene linked to a rare form of progressive hearing loss in males is identified
8. Prussian blue linked to the origin of life
9. Lifelong memories linked to stable nerve connections
10. Bacterial gut symbionts are tightly linked with the evolution of herbivory in ants
11. Sugary cola drinks linked for first time to higher risk of gestational diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/25/2015)... Feb. 25, 2015  ABC Financial Services (ABC), ... the Health and Fitness Industry, today announced enhancements ... MYiCLUBonline.  The latest upgrade includes advances to the ... cardless check-in via Identity One fingerprint biometrics. The ... through interactive displays at the International Health, Racquet ...
(Date:2/24/2015)... , Feb. 24, 2015 Research and ... the addition of the "Global 2D Gesture ... The analysts forecast the Global ... CAGR of 32.12% over the period 2014-2019 ... in non-traditional sectors is one of the major ...
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2Cepheid to Webcast Upcoming Financial Presentations 2
... with salty, undrinkable water for fish production is ... be an effective potential alternative livelihood for people ... drylands. In a report released today, researchers ... on Agricultural Research in Dryland Areas (ICARDA), and ...
... CLEVELAND November 10, 2008 A multidisciplinary research team ... Ph.D., a professor in the School of Medicine,s Department ... a number of birth defects that affect the development ... jaw, palate, brain and heart are relatively common congenital ...
... of invasive marine is one of many research results ... the First World Conference on Marine Biodiversity, Ciudad de ... report that invasive species of marine macroalgae spread at ... that covered by invasive terrestrial plants. The difference ...
Cached Biology News:'Arid aquaculture' among livelihoods promoted to relieve worsening pressure on world's drylands 2'Arid aquaculture' among livelihoods promoted to relieve worsening pressure on world's drylands 3'Arid aquaculture' among livelihoods promoted to relieve worsening pressure on world's drylands 4'Arid aquaculture' among livelihoods promoted to relieve worsening pressure on world's drylands 5Case Western Reserve University uncovers genetic basis for some birth defects 2Marine invasive species advance 50km per decade, World Conference on Marine Biodiversity told 2Marine invasive species advance 50km per decade, World Conference on Marine Biodiversity told 3Marine invasive species advance 50km per decade, World Conference on Marine Biodiversity told 4
(Date:3/4/2015)... 2015  BioClinica®, Inc., a leading specialty ... announced that clinical trial professionals representing 20 ... annual European User Conference in ... use of its eClinical technologies to overcome ... the Microsoft Office-Smart OnPoint CTMS; Express EDC; ...
(Date:3/4/2015)... , March 4, 2015 ... Paris in December 2011, ... of yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular ... expected late 2016.   SARAH, a large ... cancer (hepatocellular carcinoma, or HCC) has completed patient enrolment, ...
(Date:3/3/2015)... 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: APTO, ... molecular diagnostics that target the underlying mechanisms of cancer, ... period ended December 31, 2014. Effective July ... from May 31 to December 31. As a result ... are for the quarter and the seven months ended ...
(Date:3/3/2015)... 03, 2015 Experts and industry insiders ... one event: the Alltech REBELation exploring innovation, inspiration and ... Now in its 31st year, Alltech’s annual international conference ... and the opportunity to join the REBELation at an ... 11:59 p.m. EST, at which point the standard early ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... Md., Aug. 6 ImQuest BioSciences announced,today ... National Institutes of,Health to support the development ... topical microbicide product. ImQuest and a consortium ... will,develop a highly innovative product from the ...
... Pressure,BioSciences, Inc. (Nasdaq: PBIO ) ("PBI" ... its pressure cycling technology ("PCT")-enhanced,trypsin digestion application for ... of products. Named "Proteolysis (Trypsin)-PrEP", this new,PCT-enhanced processing ... Development of Innovative Therapeutics Expo 2008, being held,this ...
... Integrated Nanochannel Chip and Reader for,Single-Molecule Mapping, Enabling Direct ... Strands of DNA in Context and ... BioNanomatrix, Inc., a developer,of breakthrough nanoscale whole genome ... today announced,receipt of a grant from the National Human ...
Cached Biology Technology:ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission 2ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission 3Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics 2Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics 3Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics 4Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics 5BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications 2BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications 3
Coverslips for Microarrays, 1. *Category: MICROARRAY ACCESSORIES....
... ScriptCap™ 2'-O-Methyltransferase converts Cap 0 (or Cap ... Cap 1 structure has been shown to ... to 50%. This improvement is seen in ... m7G Capping System as well as those ...
Form: Ready to use Applications: ELISA...
Form: Ready to use Applications: ELISA...
Biology Products: